SpeeDx (Molecular Diagnostic)
2009
FOUNDED
PRIVATE
STATUS
Later Stage VC
LATEST DEAL TYPE
$10M
LATEST DEAL AMOUNT
8
INVESTORS
Description
Provider of molecular diagnostics solutions intended to develop innovative multiplex systems for clinical diagnostics. The company uses real-time polymerase chain reaction technology for multiplex detection and priming strategies, enabling physicians to test infectious disease and antibiotic resistance.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
- Suite G16, National Innovation Centre
- Australian Technology Park, 4 Cornwallis Street, Eveleigh
- Sydney, New South Wales 2015
- Australia
+61 (02) 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore SpeeDx (Molecular Diagnostic)’s full profile, request a free trial.
SpeeDx (Molecular Diagnostic) Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 05-Aug-2019 | $10M | 0000 | Completed | Generating Revenue | |
| 7. Later Stage VC (Series A) | 23-Apr-2019 | 000 | 000 | Completed | Generating Revenue | |
| 6. Grant | 04-Sep-2017 | 00.000 | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Grant | 01-Jul-2016 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2015 | Completed | Generating Revenue | |||
| 2. Grant | 11-May-2014 | $1.8M | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Generating Revenue |
SpeeDx (Molecular Diagnostic) Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Northpond Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Global Connections Fund | Other | 000 0000 | 000000 0 | |||
| Springboard Enterprises | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| New South Wales Medical Device Fund | Corporation | 000 0000 | 000000 0 | |||
| Cicada Innovations | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
SpeeDx (Molecular Diagnostic) Executive Team (5)
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »SpeeDx (Molecular Diagnostic) Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Andrew Denver | Self | Chairman | 000 0000 | |
| Andrew Jane | Self | Board Member | 000 0000 | |
| John Klopp | SpeeDx (Molecular Diagnostic) | Board Member | 000 0000 | |
| Michael Rubin MD | Northpond Ventures | Board Member | 000 0000 |